Syngenta, the world's largest agricultural technology company, has officially initiated its initial public offering (IPO) process on the Hong Kong Stock Exchange. According to Reuters, the company submitted a confidential IPO application on September 16. The offering is expected to raise at least $5 billion, with the potential to increase to $10 billion depending on investor demand. If successful, Syngenta could debut on the Hong Kong market by the end of this year or early next year.
Headquartered in Basel, Switzerland, Syngenta is a global company primarily controlled by Chinese state capital. In 2017, China National Chemical Corporation acquired Syngenta for approximately $43 billion, and it was later integrated under Sinochem following a merger with China National Chemical.
Currently, Syngenta operates as a private company and is the largest agricultural technology firm by revenue. It ranks first in the crop protection sector, first in the biopesticide field, and third in the seed industry. The company employs over 50,000 people across more than 90 countries.
The funds raised from this IPO will be used to pay down debt and expand investments in core businesses such as crop protection and seeds. Notably, Syngenta is increasing its investments in next-generation agricultural technologies, including artificial intelligence (AI), digital agriculture, and biological crop protection methods.
Syngenta's anticipated market capitalization is between $50 billion and $100 billion. The final valuation will be determined after the number of shares and the offering price are finalized.
In 2021, Syngenta attempted to list on the Shanghai Stock Exchange but withdrew its application due to market conditions in 2024. The recovery of the Hong Kong IPO market is also supporting Syngenta's listing efforts. So far this year, Hong Kong has raised $45.8 billion through IPOs, and Syngenta's listing is expected to be one of the largest in the recent Hong Kong market.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.

